Insights

Innovative Therapeutics Atreca's focus on developing novel cancer immunotherapeutics through its proprietary Immune Repertoire Capture technology presents opportunities to collaborate or supply specialized immune profiling services to enhance their drug discovery pipeline.

Strategic Asset Sales Recent asset sale to Immunome indicates potential for licensing or acquisition of antibody-related technologies or assets to expand their therapeutic offerings or accelerate development programs.

Leadership Expansion New executive hires in scientific and marketing leadership roles suggest growing emphasis on strategic growth and market positioning, opening avenues for suppliers in biotech marketing, leadership training, and scientific advisory services.

Collaborative Opportunities Partnership with Zymeworks to develop ADCs indicates openness to licensing and technology collaborations, creating potential sales channels for advanced linker technologies and ADC development tools.

Market Entry Focus Development of ATRC-501 for malaria prevention in collaboration with Gates MRI highlights a focus on infectious disease therapeutics, offering opportunities for sales of diagnostics, prevention tools, or clinical trial support services tailored to infectious disease programs.

Atreca, Inc. Tech Stack

Atreca, Inc. uses 8 technology products and services including git, ADP HRMS, Underscore.js, and more. Explore Atreca, Inc.'s tech stack below.

  • git
    Development
  • ADP HRMS
    Human Resource Management System
  • Underscore.js
    Javascript Libraries
  • Office 365
    Office Suites
  • Google Sheets
    Office Suites
  • ADP Payroll
    Payroll Processing
  • Linux
    Programming Languages
  • Google Analytics
    Web Analytics

Media & News

Atreca, Inc.'s Email Address Formats

Atreca, Inc. uses at least 1 format(s):
Atreca, Inc. Email FormatsExamplePercentage
FLast@atreca.comJDoe@atreca.com
72%
F.Last@atreca.comJ.Doe@atreca.com
20%
First.Last@atreca.comJohn.Doe@atreca.com
6%
Last@atreca.comDoe@atreca.com
2%

Frequently Asked Questions

What is Atreca, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Atreca, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Atreca, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Atreca, Inc. is a publicly traded company; the company's stock symbol is BCEL.

What is Atreca, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Atreca, Inc.'s official website is atreca.com and has social profiles on LinkedInCrunchbase.

What is Atreca, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Atreca, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Atreca, Inc. have currently?

Minus sign iconPlus sign icon
As of January 2026, Atreca, Inc. has approximately 17 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: H. C.Associate Director, Accounting: D. S.Sr. Director, Quality Assurance: J. S.. Explore Atreca, Inc.'s employee directory with LeadIQ.

What industry does Atreca, Inc. belong to?

Minus sign iconPlus sign icon
Atreca, Inc. operates in the Biotechnology Research industry.

What technology does Atreca, Inc. use?

Minus sign iconPlus sign icon
Atreca, Inc.'s tech stack includes gitADP HRMSUnderscore.jsOffice 365Google SheetsADP PayrollLinuxGoogle Analytics.

What is Atreca, Inc.'s email format?

Minus sign iconPlus sign icon
Atreca, Inc.'s email format typically follows the pattern of FLast@atreca.com. Find more Atreca, Inc. email formats with LeadIQ.

How much funding has Atreca, Inc. raised to date?

Minus sign iconPlus sign icon
As of January 2026, Atreca, Inc. has raised $125M in funding. The last funding round occurred on Jul 15, 2020 for $125M.

When was Atreca, Inc. founded?

Minus sign iconPlus sign icon
Atreca, Inc. was founded in 2011.

Atreca, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. With its Immune Repertoire Capture™ (IRC™) technology, Atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. Atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. 

Atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health.  If you are interested in becoming part of the Atreca team, our open positions can be found at: http://www.atreca.com/careers/

Section iconCompany Overview

Phone number
Website
atreca.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BCEL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $125M

    Atreca, Inc. has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jul 15, 2020 in the amount of $125M.

  • $1M$10M

    Atreca, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $125M

    Atreca, Inc. has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jul 15, 2020 in the amount of $125M.

  • $1M$10M

    Atreca, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.